VEGFA and diabetes mellitus: The two groups were well-matched at baseline, with no significant differences in history of diabetes, systemic health markers (serum creatinine, HbA1c), history of prior laser treatment, IOP, BCVA, surgical indications, preoperative anti-VEGF use, or the grade of proliferative traction (P > 0.05 for all).